SecBot SecBot
SC 13G ·Filed Nov 10, 2026

NVAX

NOVAVAX INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed6d 17h ago SEC0000093751-26-000697
Passive investor 5%+ stake
Actionable Insight • Neutral

This is a routine passive stake disclosure by a large index fund manager. No change in investment thesis. Monitor for any future 13D conversion or significant position changes in subsequent filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$10.20
T+0 close · Nov 10, 2026 · via day close
Latest settled
−2.16%
T+1 · $9.98
Vs SPY
−3.48%
α at T+1
Next horizon
T+5
in 5h
  1. T+0 · Nov 10 $10.20entry
  2. T+1 · 6d ago −2.16%α −3.48% · $9.98
  3. T+4 · todayOpen
  4. T+5 · in 5h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

State Street Corporation filed a Schedule 13G disclosing a passive 5.4% beneficial ownership stake in Novavax as of September 30, 2026. This is a new 13G filing for State Street on NVAX, adding to a series of prior passive filings by other institutional holders. The filing indicates no intent to influence control, consistent with State Street's role as an index fund manager.

Key Financial Metrics

Stake
5.4%
Investor
STATE STREET CORP
Investor Type
index fund

Key Facts

  • State Street Corp filed a new Schedule 13G disclosing beneficial ownership of 8,827,707 shares of Novavax common stock.
  • The stake represents 5.4% of shares outstanding as of September 30, 2026.
  • State Street certifies the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control.
  • State Street is a large index fund manager (State Street Global Advisors), making this a routine passive disclosure.

Financial Impact

8,827,707 shares, 5.4% of outstanding shares, valued at approximately $97M based on $1.8B market cap.

ownership concentration

Risk Factors

  • No material risks identified from this passive filing.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000093751-26-000697
Document: 0000093751-26-000697-index.html0000093751-26-000697
Document: 0000093751-26-000697.txt0000093751-26-000697

Track record

9 reports on NVAX

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +25.51% at T+20 after the Oct 16, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $10.20 Now $8.06 −20.98% settles Nov 17
  2. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $9.78 to $8.76 Now $8.06 −17.59% ▼ −10.43% −13.72% vs SPY
  3. Oct 29, 202618d ago 8-K Bullish 5/10 Entry $10.08 to $10.78 Now $8.06 −20.04% ▲ +6.94% +9.65% vs SPY
  4. Oct 16, 20264w ago SC 13G Neutral 4/10 Entry $10.82 to $9.40 Now $8.06 −25.51% ▼ −13.12% −12.98% vs SPY
  5. Oct 16, 20264w ago SC 13D/A Bearish 6/10 Entry $10.82 to $9.40 Now $8.06 +25.51% ▲ +13.12% +12.98% vs SPY
  6. Aug 6, 202614w ago 8-K Neutral 5/10 Entry $7.74 to $8.14 Now $8.06 +4.13% ▲ +5.17% +3.96% vs SPY
  7. May 6, 202627w ago 8-K Neutral 4/10 Entry $9.36 to $9.62 Now $8.06 −13.89% ▲ +2.78% +1.65% vs SPY
  8. Apr 27, 202629w ago DEFA14A Neutral 2/10 Entry $8.07 to $8.03 Now $8.06 −0.12% ▼ −0.50% −0.90% vs SPY
  9. Feb 26, 202637w ago 8-K Bullish 8/10 Entry $11.19 to $9.99 Now $8.06 −27.97% ▼ −10.72% −9.60% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens in 7h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026